We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Enanta Files Suit Against Pfizer for Patent Violation in Paxlovid Development
Enanta Files Suit Against Pfizer for Patent Violation in Paxlovid Development
Enanta Pharmaceuticals is accusing Pfizer of patent infringement, claiming Paxlovid (nirmatrelvir tablets; ritonavir tablets) is in violation of Encanta’s patent for its under-development antiviral COVID pill.